Vaccines | CHOP Research Institute
 

Vaccines

Dr. Alameh is focused on designing, synthetizing, optimizing, and understanding the structure-activity relationships of nucleic acid delivery systems and biomaterials, and their associated properties to improve the safety, reactogenicity, and potency of emerging mRNA therapeutics and vaccines.

E-mail:
alamehm [at] chop.edu
Published on
Oct 30, 2024
Adam Wolpaw, MD, PhD, and Timothy Spear, MD, PhD, have been awarded grants from Hyundai Hope On Wheels to improve CAR T-cell therapy.
Published on
Sep 5, 2024
Charlotte Moser of CHOP’s Vaccine Education Center offers three ways for researchers to engage, inform, and build trust with non-scientific audiences in an increasingly polarized, digital world.
Published on
Apr 3, 2024
Celebrate Diversity Month this April with Ama Onwuka, who shares her insight on how diversity impacts scientific breakthroughs.
Published on
Jun 23, 2023
U.S. News & World Report ranks CHOP No. 1 in region, and we’re proud to have eight specialties ranked in the top five.

This research is studying a vaccine against Mpox (formerly known as monkeypox) that is FDA approved for adults but not yet approved for children. 
 

Published on
Dec 30, 2021
Here’s our list of the 2021 Cornerstone stories our social media followers engaged with the most.
Published on
Nov 10, 2021
Our Faculty Spotlight features Paul Offit, MD, director of the Vaccine Education Center at CHOP.

Our lab designs novel genetic, chemistry and engineering tools to dissect immune cell-cell and cell-tissue crosstalk and leverages these crosstalk mechanisms to develop biomaterials, protein, and cell-based precision immunotherapies.

Dr. Ma focuses on immune engineering. He leverages genetic, chemistry, and engineering tools to dissect immune cell-cell and cell-tissue crosstalk and harness these crosstalk mechanisms to develop biomaterials, protein, and cell-based precision immunotherapies for cancer and autoimmune diseases.

E-mail:
mal5 [at] chop.edu